Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma

The incidence of metabolic syndrome with fatty liver is spreading on a worldwide scale. Correspondingly, the number of patients with the hepatic phenotype of metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and in its advanced states, non-alcoholic steatohepatitis (NASH), and the subse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kazuki Takakura, Tsunekazu Oikawa, Masanori Nakano, Chisato Saeki, Yuichi Torisu, Mikio Kajihara, Masayuki Saruta
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019-08-01
Col·lecció:Frontiers in Oncology
Matèries:
hepatocellular carcinoma
non-alcoholic steatohepatitis
non-alcoholic fatty liver disease
tumor necrosis factor
dysbiosis
signal transducer and activator of transcription
Accés en línia:https://www.frontiersin.org/article/10.3389/fonc.2019.00762/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars